A medical worker administers a dose of the recombinant COVID-19 vaccine (adenovirus type 5 vector) which requires only one shot to a resident at a temporary vaccination site in Haidian District of Beijing, capital of China, May 20, 2021. (Xinhua/Ren Chao)
